Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dow Corning settlement

This article was originally published in The Gray Sheet

Executive Summary

Nevada breast implant claimants drop suit against parent company Dow Chemical March 19, clearing the way for Dow Corning to complete bankruptcy proceedings. Administrators of the firm's $2.35 bil. silicone gel-filled breast implant liability settlement fund will begin processing claims, releasing checks to claimants by June 15. Dow Corning filed for bankruptcy in 1995. In 2002, a previous obstacle to the payments was removed via settlement with the government - providing $9.8 mil. to cover Medicare claims of women treated for alleged implant-related illnesses (1"The Gray Sheet" Sept. 30, 2002, In Brief)...

Nevada breast implant claimants drop suit against parent company Dow Chemical March 19, clearing the way for Dow Corning to complete bankruptcy proceedings. Administrators of the firm's $2.35 bil. silicone gel-filled breast implant liability settlement fund will begin processing claims, releasing checks to claimants by June 15. Dow Corning filed for bankruptcy in 1995. In 2002, a previous obstacle to the payments was removed via settlement with the government - providing $9.8 mil. to cover Medicare claims of women treated for alleged implant-related illnesses (1 'The Gray Sheet' Sept. 30, 2002, In Brief)....

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020008

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel